NCT04151108View on ClinicalTrials.gov

Biomarkers for Length of Hospital Stay and Loss of Muscle Mass and Function in Old Medical Patients

CompletedOBSERVATIONAL
Enrollment

1,072

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

November 1, 2021

Study Completion Date

February 1, 2022

Conditions
SarcopeniaMuscle LossLength of Stay
Interventions
OTHER

Development of a risk assessment tool based on clinical and functional measures and systemic biomarkers

Blood tests, frailty (CSHA Clinical Frailty Scale) and risk of pressure ulcers (Braden Score), Early Warning Score (EWS), sarcopenia (SARC-F), malnutrition (SNAQ), cognitive status, comorbidity (Charlson comorbidity Index), polypharmacy, muscle strength, and body composition (BIA)

OTHER

Development of a risk assessment tool for loss of muscle mass and physical function based on clinical and functional measures and systemic biomarkers

Blood tests, frailty (CSHA Clinical Frailty Scale), Early Warning Score (EWS), cognitive status, sarcopenia (SARC-f), malnutrition (SNAQ), comorbidity (Charlson comorbidity Index), polypharmacy, physical function, physical performance, and body composition (BIA)

Trial Locations (1)

2400

Bispebjerg Hospital, Copenhagen

All Listed Sponsors
lead

Bispebjerg Hospital

OTHER

NCT04151108 - Biomarkers for Length of Hospital Stay and Loss of Muscle Mass and Function in Old Medical Patients | Biotech Hunter | Biotech Hunter